Skip to search formSkip to main contentSkip to account menu

Leprosy, Paucibacillary

Known as: Leprosies, Paucibacillary, Leprosy, Paucibacillary [Disease/Finding], Tuberculoids, Borderline 
A form of LEPROSY classified by the World Health Organization for the purpose of treatment, based on clinical manifestations and skin smear results… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
We recently showed that Mycobacterium leprae (ML) is able to induce lipid droplet formation in infected macrophages. We herein… 
Highly Cited
2007
Highly Cited
2007
ABSTRACT Leprosy is a chronic and debilitating human disease caused by infection with the Mycobacterium leprae bacillus. Despite… 
Highly Cited
2003
Highly Cited
2003
Two months after starting highly active antiretroviral treatment (HAART), an individual with human immunodeficiency virus type 1… 
Highly Cited
1999
Highly Cited
1999
OBJECTIVE To investigate the relation between lesions and cellular immune response-based tests in sheep with naturally acquired… 
Highly Cited
1995
Highly Cited
1995
Leprosy may be complicated by episodes of increased cell‐mediated immunity towards Mycobacterium leprae (reversal reactions… 
Highly Cited
1994
Highly Cited
1994
Lymphoproliferation and gamma interferon (IFN-gamma) secretion in response to 28 overlapping 20-mer synthetic peptides covering… 
Review
1993
Review
1993
A retrospective survey of the notes on all patients attending Dhoolpet Leprosy Research Center, India, during 1985 was done to… 
Highly Cited
1976
Highly Cited
1976
Lymphocyte transformation tests (LTT) using 'whole washed" and 'sonicated" preparations of Mycobacterium leprae (M. leprae) as…